SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-064395
Filing Date
2024-03-11
Accepted
2024-03-11 08:47:53
Documents
16
Period of Report
2024-03-11
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d808382d8k.htm   iXBRL 8-K 42812
2 EX-3.1 d808382dex31.htm EX-3.1 5369
3 EX-3.2 d808382dex32.htm EX-3.2 69325
  Complete submission text file 0001193125-24-064395.txt   271790

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA harp-20240311.xsd EX-101.SCH 2857
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE harp-20240311_lab.xml EX-101.LAB 19483
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE harp-20240311_pre.xml EX-101.PRE 12158
17 EXTRACTED XBRL INSTANCE DOCUMENT d808382d8k_htm.xml XML 3992
Mailing Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080 (650) 443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38800 | Film No.: 24736691
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)